Recent advances in oxazolidinones as antituberculosis agents.

Haijia Lu, Huahao Wang, Hongyi Zhao, Dongfeng Zhang

Future medicinal chemistry 2022 Aug

filter terms:

Tuberculosis (TB) is an infectious and fatal disease caused by Mycobacterium tuberculosis (Mtb) and remains a serious public health threat; therefore, the development of new antitubercular agents is a priority for the World Health Organization's End TB strategy and the United Nations' Sustainable Development Goals to eradicate TB. Oxazolidinones are a class of synthetic antibacterial agents with a distinct mode of action developed for the treatment of Gram-positive bacterial infections. Many oxazolidinones exhibit good activity against Mtb, and some are currently in clinical trials for multidrug-resistant TB and extensively drug-resistant TB therapy. In this review, the mechanism of action, activity and toxicity of oxazolidinones and recent progress in the research and development of oxazolidinones as anti-TB agents are summarized.

Citation

Haijia Lu, Huahao Wang, Hongyi Zhao, Dongfeng Zhang. Recent advances in oxazolidinones as antituberculosis agents. Future medicinal chemistry. 2022 Aug;14(15):1149-1165